Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (3)

Folia Pharmacologica Japonica

Volumn 108, Issue 5, 1996, Pages 259-266

  Kimura, Isami ^a   Nagahama, Shinobu ^a   Kawasaki, Maki ^a   Kataoka, Mikiko ^a   Sato, Makoto ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; DOCEBENONE; FREE RADICAL; INDOMETACIN; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE; MESALAZINE; OZAGREL; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; NONHUMAN; RAT; RECTAL DRUG ADMINISTRATION; SYMPTOMATOLOGY; ULCERATIVE COLITIS;

EID: 0029860928     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.108.259     Document Type: Article

References (34)

1. Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, Rognum TO, Scott H and Sollid M: Immunobiology and immunopathology of human gut mucosa: Humoral immunity and intraperitoneal lymphocytes. Gastroenterology 97, 1562-1584 (1989)
2. Kobayashi K, Asakura H, Hamada Y, Hibi T, Watanabe M, Yoshida T, Watanabe N, Miura S, Aiso S and Tsuchiya M: T lymphocyte subpopulations and immunoglobulin-containing cells in the colonic mucosa of ulcerative colitis: A morphometoric and immunohistochemical study. J Clin Lab Immunol 25, 63-68 (1988)
3. Lauritsen K, Lauren LS, Bukhave K and Rask-Madsen J: Inflammatory mediators in inflammatory bowel disease. Edited by Mac Dermott RP and Stenson WF, pp 201-223, Elsevier (1992)
4. Vilaseca J, Salas A, Guarner F, Rodriguez R and Malagelade JR: Participation of thromboxane and other eicosanoid synthesis in the course of experimental inflammatory colitis. Gastroenterology 98, 269-277 (1990)
5. 4 levels determined by in vivo dialysis of rectum in relapsing ulcerative colitis. Gastroenterology 91, 837-844 (1986)
6. 4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86, 453-460 (1984)
7. Metronidazole 84, 2337-2346 (1987)
8. Takizawa H, Shintani N, Natsui M, Sasakawa T, Nakakubo H, Nakajima T and Asakura H: Activated immunocompetent cells in rat colitis mucosal induced by dextran sulfate sodium and not complete but partial suppression of colitis by FK506. Digestion 56, 259-264 (1995)
9. MacPherson BR and Pfeiffer CJ: Experimental colitis. Digestion 14, 424-452 (1976)
10. Okabe N, Kuroiwa A, Fujita K, Shibuya T, Yao T and Okumura M: Immunological studies on Crohn's disease. IV. Increased chemiluminescent response of peripheral blood monocytes. J Clin Lab Immunol 21, 11-15 (1986)
11. Suematsu M, Suzuki M, Kitahora T, Miura S, Suzuki K, Hibi T, Watanabe M, Nagata H, Asakura H and Tsuchiya M: Increased respiratory burst of leukocytes in inflammatory bowel disease - The analysis of free radical generation by using chemiluminescence probe. J Clin Lab Immunol 24, 125-128 (1987)
12. Shiratori Y, Aoki S and Takeda H: Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 44, 163-167 (1989)
13. recombinant-human-SOD 88, 1902 (1991)
14. Simonds NJ, Allen RE, Stevens TRJ, van Someren RNM, Blake DR and Rampton DS: Chemiluminescence of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 103, 186-196 (1992)
15. Timothy SG and Robin EW: Sulfasalazine. Multiplicity of Action. Dig Dis Sci 37, 801-812 (1992)
16. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231, 232-235 (1971)
17. Gould SR: Prostaglandins, ulcerative colitis, and sulphasalazine. Lancet II, 988 (1975)
18. 2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibitory steroids and sulfasalazine. Gastroenterology 81, 444-449 (1981)
19. Rampton DS, McNeil NI and Sarner M: Analgesic ingestion and other factors preceding relapse in ulcerative colitis. Gut 24, 187-189 (1983)
20. Rampton DS and Sladen GE: Prostaglandin synthesis inhibitors in ulcerative colitis: Flurbiprofen compared with conventional treatment. Prostaglandins 21, 417-425 (1981)
21. Schumert R, Towner J and Zipser R: Role of eicosanoids in human and experimental colitis. Dig Dis Sci 33, 58S-64S (1988)
22. 4. Dig Dis Sci 32, 1380-1388 (1987)
23. Lauritsen K, Laursen LS, Bukhave K and Rask-Madsen J: In vivo effects of orally administered prednisolone on prostaglandin and leukotriene production in ulcerative colitis. Gut 28, 1095-1099 (1987)
24. Collawn C, Rubin P, Perez N, Bodadila J, Cabrera G, Reyes E, Borovoy J and Kershenobich D: Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis. Am J Gastroenterol 87, 342-346 (1992)